$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
FDA授予了futibatinib治疗胆管癌的突破性治疗资格认定
2025-10-19 11:44:20
Check Details
FDA授予艾伏尼布优先审评资格用于IDH1突变型胆管癌
2025-10-19 11:44:20
Check Details
【重磅】胆管癌首款靶向治疗药物-培美替尼
2025-10-19 11:44:20
Check Details
培美替尼在国内买的到吗?多少钱一盒?纳入医保了吗?
2025-10-19 11:44:20
Check Details
【热点】培美替尼使胆管癌患者有了靶向疗法
2025-10-19 11:44:20
Check Details
靶向药培美替尼的问世是肝内胆管癌患者的福音
2025-10-19 11:44:20
Check Details
【关注度高】靶向药培美替尼改变了肝内胆管癌的治疗现状
2025-10-19 11:44:20
Check Details
培美替尼是世上首个肝内胆管癌靶向药
2025-10-19 11:44:20
Check Details
【医保动态】培美替尼在中国纳入国家医保目录了吗?
2025-10-19 11:44:20
Check Details
培美替尼使胆管癌患者有了新的治疗先择
2025-10-19 11:44:20
Check Details
【患者关心】培美替尼治疗肝内胆管癌的疗效分析
2025-10-19 11:44:20
Check Details
培美替尼价格多少一盒?培美替尼2021年最新价格
2025-10-19 11:44:20
Check Details
1
2
...
25
26
27
28
29
30
31
...
4155
4156
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Cabozantinib: A Pan-Targeted TKI in Modern Oncology Practice
2
Managing Amivantamab Infusion Reactions: A Clinical Guide for International Practice
3
Onset Timeline and Efficacy Assessment of Margetuximab plus Chemotherapy in HER2-Positive Metastatic Breast Cancer
4
Avutometinib Plus Defactinib: A Precision Therapy for KRAS-Mutant Recurrent Low-Grade Serous Ovarian Cancer
5
Vemurafenib (Zelboraf) Complete Medication Guide
6
Durvalumab Safety Profile: Managing Immune-Related Adverse Events (irAEs) in Clinical Practice
7
Zolbetuximab Combination Therapy: Global Efficacy and Safety Profile in CLDN18.2-Positive Advanced Gastric Cancer
8
Managing Mitotane Resistance in Adrenocortical Carcinoma: Strategies and Global Options
9
Trametinib & Dabrafenib in 2026: A Global Guide to Treating BRAF-Mutant Cancers
10
A Guide to Safely Stopping Mitotane: Why Tapering is Essential and How to Manage
11
Pemigatinib Efficacy: Significantly Improving Survival in FGFR2-Fusion Cholangiocarcinoma
12
Erlotinib: Targeting EGFR Mutations to Precisely Inhibit Non-Small Cell Lung Cancer Growth